Insider filing · ROIV
Frank Torti
President and Vant Chair
profile →
Roivant Sciences Ltd.
ROIV · Healthcare · 75 filings in 24 months
ticker →
Frank Torti sold $82.0M of Roivant Sciences (ROIV)
Executed Feb 19, disclosed Feb 23, 4 days later.
Value, as filed
$82.0M
3,000,000 sh across 3 lots
Executed
Feb 19
the trade date, as filed
Disclosed
Feb 23
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FTFrank Torti (President and Vant Chair) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $82.0M of ROIV (3,000,000 sh across 3 lots, as filed), executed Feb 19.
The name
ROIVHealthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→